Evidence-based medicine (EBM), previously translational medicine, can be defined as improving care based on empirical research and/or hands-on practice. The EBM’s approach is based on either direct patient care (bottom-up) or an experiment translated into guidelines (top-down). EBM is used in either in conjunction or as quality assessment tool(s) for continuous quality improvement (CQI). The healthcare leader must utilize the evidence to promote healthcare quality.

• Explain      the process of evidence-based analysis.
• Highlight      the major players and their roles in EBM policy (i.e., government,      providers, patients, etc.).
• Explain      the EBM “Levels of Evidence” as defined in your course text.
• Review the      case “Constraints of the ACA on Evidence-Based Medicine.”
• Provide a      written analysis of the case “Constraints of the ACA on Evidence-Based      Medicine” in Chapter 9 of your textbook. (Utilize the  “Levels      of  Evidence and Grades of  Recommendations” as defined by the      University of Minnesota) Clearinghouse.
• Summarize      the policy of EBM in your conclusion.

Your paper

• Must be      four to six double-spaced pages in length (not including title and reference      pages) and formatted according to APA style 
• Must use      at least four scholarly sources